Methicillin-Resistant Staphylococcus Aureus (MRSA)
Guidance to Patients with Primary Immune Deficiencies
Methicillin-resistant Staphylococcus aureus bacteria, often referred to as MRSA, has become a significant infection problem both in hospitals and in the general community. It is a type of staph that is resistant to methicillin and other commonly used antibiotics in the same class, including penicillin, amoxicillin, and oxacillin. While MRSA is of concern to everyone, patients with a variety of primary immune deficiencies (PID) may be at increased risk.
An article titled "Methicillin-Resistant Staphylococcus aureus (MRSA) Guidance to Patients with Primary Immune Deficiencies," by Frank R. DeLeo, PhD and Harry L. Malech, MD, is now available HERE. There are two sections in the article. One is a Lay Language Discussion, which is followed by a Scientific Language Discussion complete with references.
[PRINTER FRIENDLY VERSION]
|